VERVE THERAPEUTICS, INC. (NASDAQ: VERV) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Verve Therapeutics, Inc. Investors of Upcoming Deadline
NEW YORK, Oct. 14, 2024 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP: Do you, or did you, own shares of Verve Therapeutics, Inc. (NASDAQ: VERV)? Did you purchase your shares between August 9, 2022 and April 1, 2024, inclusive? Did you lose money in your investment in Verve Therapeutics, Inc.? Do you want to discuss your […]